Association of BRCA1 germline mutations in young onset triple-negative breast cancer (TNBC)-Reference-Cited by-同舟云学术

Association of BRCA1 germline mutations in young onset triple-negative breast cancer (TNBC)

Published:2013-08-27 Issue:3 Volume:16 Page:280-284
ISSN:1699-048X
Container-title:Clinical and Translational Oncology
language:en
Short-container-title:Clin Transl Oncol

Author:

Andrés R.,Pajares I.,Balmaña J.,Llort G.,Ramón y Cajal T.,Chirivella I.,Aguirre E.,Robles L.,Lastra E.,Pérez-Segura P.,Bosch N.,Yagüe C.,Lerma E.,Godino J.,Miramar M. D.,Moros M.,Astier P.,Saez B.,Vidal M. J.,Arcusa A.,Ramón y Cajal S.,Calvo M. T.,Tres A.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12094-013-1070-9.pdf

Reference23 articles.

1. Mavaddat N, Rebbeck TR, Lakhani SR, Eaton DF, Antoniou AC. Incorporating tumour pathology information into breast cancer risk prediction algorithms. Breast Cancer Res. 2010;12(3):R28.

2. James PA, Doherty R, Harris M, Mukesh BN, Milner A, Young MA, et al. Optimal selection of individuals for BRCA mutation testing: a comparison of available methods. J Clin Oncol. 2006;24(4):707–15.

3. Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cáncer families. The Breast Cancer Linkage Consortium. Am J Hum Genet. 1998;62(3):676–89.

4. Palacios J, Honrado E, Osorio A, Cazorla A, Sarrió D, Barroso A, et al. Phenotypic characterization of BRCA1 y BRCA2 tumors based in a tissue microarray study with 37 immunohistochemical markers. Breast Cancer Res Treat. 2005;90(1):5–14.

5. Eerola H, Heikkilä P, Tamminen A, Aittomäki K, Blomqvist C, Nevanlinna H, et al. Histopathological features of breast tumor in BRCA1, BRCA2 and mutation-negative breast cancer families. Breast Cancer Res. 2005;7(1):R93–100.

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of three miRNA signature as potential diagnostic marker for triple negative breast cancer patients;Scientific Reports;2023-12-08

2. The oncogenic miR-429 promotes triple-negative breast cancer progression by degrading DLC1;Aging;2023-09-21

3. Study of the Genetic Variants in BRCA1/2 and Non-BRCA Genes in a Population-Based Cohort of 2155 Breast/Ovary Cancer Patients, Including 443 Triple-Negative Breast Cancer Patients, in Argentina;Cancers;2021-05-31

4. Modulatory Role of microRNAs in Triple Negative Breast Cancer with Basal-Like Phenotype;Cancers;2020-11-07

5. PARP inhibitors in the treatment of metastatic breast cancer patients with germline BRCA1/2 mutations. Experience of treatment with talazoparib in clinical practice;Meditsinskiy sovet = Medical Council;2020-07-30